MacroGenics

$31.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.39 (-1.24%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell MacroGenics and other stocks, options, and ETFs commission-free!

About MGNX

MacroGenics, Inc. Common Stock, also called MacroGenics, is a clinical-stage biopharmaceutical company, which engages in discovering and developing antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer.

CEO
Scott E. Koenig
Employees
370
Headquarters
Rockville, Maryland
Founded
2000
Market Cap
1.89B
Price-Earnings Ratio
Dividend Yield
Average Volume
504.26K
High Today
$31.57
Low Today
$30.65
Open Price
$31.57
Volume
527.96K
52 Week High
$33.61
52 Week Low
$5.00

MGNX Earnings

-$1.02
-$0.67
-$0.33
$0.02
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 4, After Hours

You May Also Like

CDL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure